Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology. FREMONT,…
FROM GRIT TO GLORY. THE HEAD TITANS WHO LEFT THEIR MARK IN THE CLAY
How our athletes dominated the French tournament with power, precision & passion.As…
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd (“Avistone”), an innovative biotechnology company focused…
Catheter Precision, Inc. Receives CE Mark for LockeT
Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units…
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
May 23, 2025 16:05 ET | Source: PMV Pharmaceuticals, Inc. PRINCETON, N.J.,…
Lamborghini Super Trofeo North America WeatherTech Raceway Laguna Seca 2025 Weekend PostRace
Sant'Agata Bolognese/Monterey, May 11, 2025 – Wayne Taylor Racing added four victories…
Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference
Fort Lee, NJ, May 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc.…
Alamar Biosciences Expands NULISAseq CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays
First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to…
Autonomix CEO Brad Hauser to Present at Virtual Investors Closing Bell Event
Live webcast followed by an interactive Q&A session on Thursday, May 22nd…
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
May 14, 2025 09:15 ET | Source: Renovaro Inc New Proprietary Target…